DKK 248.2
(4.9%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | 4.14 Billion DKK | 29.34% |
2022 | 3.2 Billion DKK | -6.91% |
2021 | 3.44 Billion DKK | 125.16% |
2020 | 1.53 Billion DKK | -28.87% |
2019 | 2.15 Billion DKK | -15.05% |
2018 | 2.53 Billion DKK | 8.3% |
2017 | 2.33 Billion DKK | 20.39% |
2016 | 1.94 Billion DKK | 3.41% |
2015 | 1.87 Billion DKK | 6.64% |
2014 | 1.76 Billion DKK | -1.29% |
2013 | 1.78 Billion DKK | 7.92% |
2012 | 1.65 Billion DKK | -3.28% |
2011 | 1.7 Billion DKK | 19.52% |
2010 | 1.42 Billion DKK | 24.4% |
2009 | 1.14 Billion DKK | -5.69% |
2008 | 1.21 Billion DKK | -3.85% |
2007 | 1.26 Billion DKK | -0.23% |
2006 | 1.27 Billion DKK | 15.21% |
2005 | 1.1 Billion DKK | 9.87% |
2004 | 1 Billion DKK | 17.32% |
2003 | 855.54 Million DKK | 5.6% |
2002 | 810.15 Million DKK | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q1 | 1.09 Billion DKK | -46.72% |
2024 Q2 | 1.09 Billion DKK | 0.0% |
2023 FY | 4.14 Billion DKK | 29.34% |
2023 Q4 | 2.05 Billion DKK | 94.33% |
2023 Q3 | 1.05 Billion DKK | -51.31% |
2023 Q2 | 2.17 Billion DKK | 119.49% |
2023 Q1 | 990.5 Million DKK | -30.05% |
2022 Q4 | 1.41 Billion DKK | 80.27% |
2022 Q3 | 785.5 Million DKK | -47.81% |
2022 Q1 | 769 Million DKK | -54.31% |
2022 Q2 | 1.5 Billion DKK | 95.71% |
2022 FY | 3.2 Billion DKK | -6.91% |
2021 Q1 | 812 Million DKK | -44.65% |
2021 Q3 | 897.5 Million DKK | -46.03% |
2021 Q4 | 1.68 Billion DKK | 87.52% |
2021 Q2 | 1.66 Billion DKK | 104.8% |
2021 FY | 3.44 Billion DKK | 125.16% |
2020 Q1 | -95 Million DKK | -110.76% |
2020 Q2 | 278 Million DKK | 392.63% |
2020 Q3 | 616.5 Million DKK | 121.76% |
2020 Q4 | 1.46 Billion DKK | 137.96% |
2020 FY | 1.53 Billion DKK | -28.87% |
2019 Q1 | 537.5 Million DKK | -17.31% |
2019 FY | 2.15 Billion DKK | -15.05% |
2019 Q2 | 1.07 Billion DKK | 99.81% |
2019 Q3 | 434.5 Million DKK | -59.54% |
2019 Q4 | 883 Million DKK | 103.22% |
2018 Q3 | 650 Million DKK | 6.64% |
2018 Q1 | 609.5 Million DKK | -8.07% |
2018 Q4 | 650 Million DKK | 0.0% |
2018 FY | 2.53 Billion DKK | 8.3% |
2018 Q2 | 609.5 Million DKK | 0.0% |
2017 FY | 2.33 Billion DKK | 20.39% |
2017 Q4 | 663 Million DKK | 0.0% |
2017 Q3 | 663 Million DKK | 18.39% |
2017 Q2 | 560 Million DKK | 0.0% |
2017 Q1 | 560 Million DKK | -3.95% |
2016 Q1 | 438.5 Million DKK | -11.77% |
2016 Q2 | 438.5 Million DKK | 0.0% |
2016 Q3 | 583 Million DKK | 32.95% |
2016 FY | 1.94 Billion DKK | 3.41% |
2016 Q4 | 583 Million DKK | 0.0% |
2015 FY | 1.87 Billion DKK | 6.64% |
2015 Q4 | 497 Million DKK | 0.0% |
2015 Q3 | 497 Million DKK | 16.53% |
2015 Q2 | 426.5 Million DKK | 0.0% |
2015 Q1 | 426.5 Million DKK | 7.97% |
2014 Q4 | 395 Million DKK | 0.0% |
2014 Q3 | 395 Million DKK | -7.28% |
2014 Q1 | 426 Million DKK | 11.23% |
2014 FY | 1.76 Billion DKK | -1.29% |
2014 Q2 | 426 Million DKK | 0.0% |
2013 FY | 1.78 Billion DKK | 7.92% |
2013 Q4 | 383 Million DKK | 0.0% |
2013 Q3 | 383 Million DKK | -12.86% |
2013 Q2 | 439.5 Million DKK | 0.0% |
2013 Q1 | 439.5 Million DKK | 11.55% |
2012 Q1 | 410.25 Million DKK | -3.98% |
2012 Q2 | 410.25 Million DKK | 0.0% |
2012 FY | 1.65 Billion DKK | -3.28% |
2012 Q3 | 394 Million DKK | -3.96% |
2012 Q4 | 394 Million DKK | 0.0% |
2011 Q1 | 427.25 Million DKK | 19.52% |
2011 Q4 | 427.25 Million DKK | 0.0% |
2011 FY | 1.7 Billion DKK | 19.52% |
2011 Q3 | 427.25 Million DKK | 0.0% |
2011 Q2 | 427.25 Million DKK | 0.0% |
2010 Q4 | 357.47 Million DKK | 0.0% |
2010 Q2 | 357.47 Million DKK | 0.0% |
2010 Q3 | 357.47 Million DKK | 0.0% |
2010 Q1 | 357.47 Million DKK | 24.38% |
2010 FY | 1.42 Billion DKK | 24.4% |
2009 FY | 1.14 Billion DKK | -5.69% |
2009 Q1 | 287.4 Million DKK | -5.68% |
2009 Q2 | 287.4 Million DKK | 0.0% |
2009 Q3 | 287.4 Million DKK | 0.0% |
2009 Q4 | 287.4 Million DKK | 0.0% |
2008 FY | 1.21 Billion DKK | -3.85% |
2008 Q4 | 304.7 Million DKK | 0.0% |
2008 Q3 | 304.7 Million DKK | 0.0% |
2008 Q2 | 304.7 Million DKK | 0.0% |
2008 Q1 | 304.7 Million DKK | -4.28% |
2007 Q4 | 318.32 Million DKK | 0.0% |
2007 Q3 | 318.32 Million DKK | 0.0% |
2007 FY | 1.26 Billion DKK | -0.23% |
2007 Q2 | 318.32 Million DKK | 0.0% |
2007 Q1 | 318.32 Million DKK | -0.1% |
2006 Q2 | 318.62 Million DKK | 0.0% |
2006 Q3 | 318.62 Million DKK | 0.0% |
2006 Q4 | 318.62 Million DKK | 0.0% |
2006 Q1 | 318.62 Million DKK | 14.0% |
2006 FY | 1.27 Billion DKK | 15.21% |
2005 Q1 | 279.48 Million DKK | 10.2% |
2005 Q4 | 279.48 Million DKK | 0.0% |
2005 FY | 1.1 Billion DKK | 9.87% |
2005 Q3 | 279.48 Million DKK | 0.0% |
2005 Q2 | 279.48 Million DKK | 0.0% |
2004 Q1 | 253.61 Million DKK | 22.62% |
2004 Q2 | 253.61 Million DKK | 0.0% |
2004 FY | 1 Billion DKK | 17.32% |
2004 Q3 | 253.61 Million DKK | 0.0% |
2004 Q4 | 253.61 Million DKK | 0.0% |
2003 Q1 | 206.83 Million DKK | 6.15% |
2003 FY | 855.54 Million DKK | 5.6% |
2003 Q4 | 206.83 Million DKK | 0.0% |
2003 Q3 | 206.83 Million DKK | 0.0% |
2003 Q2 | 206.83 Million DKK | 0.0% |
2002 Q4 | 194.84 Million DKK | 0.0% |
2002 FY | 810.15 Million DKK | 0.0% |
2002 Q1 | 194.84 Million DKK | 0.0% |
2002 Q2 | 194.84 Million DKK | 0.0% |
2002 Q3 | 194.84 Million DKK | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
Ambu A/S | 645 Million DKK | -543.101% |
ChemoMetec A/S | 178.78 Million DKK | -2220.144% |
GN Store Nord A/S | 869 Million DKK | -377.33% |
Scandinavian Medical Solutions A/S | 16.62 Million DKK | -24847.909% |
ViroGates A/S | -12.56 Million DKK | 33112.336% |